To adhere to the PRISMA protocol, the reviewers started by conducting a thorough search of the literature to identify all relevant studies on TGF-β1 polymorphism and TGF-β1 levels and their association with cirrhosis and hepatitis C, as represented in Figure 1. The gene discussed is TGFB1; the disease is hepatitis C virus infection.